• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T细胞受体见解:主要组织相容性复合体I类与II类识别的决定因素

T-cell receptor insights: Determinants of Major Histocompatibility Complex class I versus class II recognition.

作者信息

De Almeida Mendes Marcus, Chihab Leila, Nilsson Jonas Birkelund, Scheffer Lonneke, Nielsen Morten, Peters Bjoern

机构信息

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, San Diego, California, USA.

Department of Health Technology, Technical University of Denmark, Copenhagen, Denmark.

出版信息

Protein Sci. 2025 Sep;34(9):e70262. doi: 10.1002/pro.70262.

DOI:10.1002/pro.70262
PMID:40815345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12356138/
Abstract

In this study, we analyzed large-scale T-cell receptor (TCR) sequence data to determine whether TCRs preferentially bind to major histocompatibility complex (MHC) class I (CD8+) or class II (CD4+) epitopes. Using the International ImMunoGeneTics information system numbering scheme, we identified specific positions with distinct amino acid enrichment for each MHC class and developed machine learning models for classification. While our frequency-based approach effectively differentiated MHC-I from MHC-II TCRs in cross-validation, performance declined when only beta chain data were used from real-world peripheral blood mononuclear cell samples. However, incorporating the TCR alpha chain significantly improved accuracy, emphasizing its importance for MHC recognition. Overall, we found that V-region loops can signal MHC class bias, aiding in immunotherapy design and TCR repertoire analysis, while highlighting the need for larger, more diverse datasets for reliable predictions.

摘要

在本研究中,我们分析了大规模的T细胞受体(TCR)序列数据,以确定TCR是否优先结合主要组织相容性复合体(MHC)I类(CD8 +)或II类(CD4 +)表位。使用国际免疫遗传学信息系统编号方案,我们确定了每个MHC类具有不同氨基酸富集的特定位置,并开发了用于分类的机器学习模型。虽然我们基于频率的方法在交叉验证中有效地区分了MHC-I和MHC-II TCR,但当仅使用来自真实外周血单核细胞样本的β链数据时,性能会下降。然而,纳入TCRα链显著提高了准确性,强调了其对MHC识别的重要性。总体而言,我们发现V区环可以指示MHC类偏向,有助于免疫治疗设计和TCR库分析,并突出了需要更大、更多样化的数据集进行可靠预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/569f/12356138/b1dc44ae23d8/PRO-34-e70262-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/569f/12356138/69e722603e41/PRO-34-e70262-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/569f/12356138/df04d24daf4f/PRO-34-e70262-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/569f/12356138/2aed2d9d5e48/PRO-34-e70262-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/569f/12356138/942e4dd0b546/PRO-34-e70262-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/569f/12356138/cfceb5ec6f39/PRO-34-e70262-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/569f/12356138/b1dc44ae23d8/PRO-34-e70262-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/569f/12356138/69e722603e41/PRO-34-e70262-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/569f/12356138/df04d24daf4f/PRO-34-e70262-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/569f/12356138/2aed2d9d5e48/PRO-34-e70262-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/569f/12356138/942e4dd0b546/PRO-34-e70262-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/569f/12356138/cfceb5ec6f39/PRO-34-e70262-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/569f/12356138/b1dc44ae23d8/PRO-34-e70262-g002.jpg

相似文献

1
T-cell receptor insights: Determinants of Major Histocompatibility Complex class I versus class II recognition.T细胞受体见解:主要组织相容性复合体I类与II类识别的决定因素
Protein Sci. 2025 Sep;34(9):e70262. doi: 10.1002/pro.70262.
2
On the impact of local protein structure features on prediction of major histocompatibility complex class I and II antigen presentation.局部蛋白质结构特征对主要组织相容性复合体I类和II类抗原呈递预测的影响
Brief Bioinform. 2025 Jul 2;26(4). doi: 10.1093/bib/bbaf402.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
NetMHCpan-4.2: improved prediction of CD8+ epitopes by use of transfer learning and structural features.NetMHCpan-4.2:通过使用迁移学习和结构特征改进对CD8+表位的预测
Front Immunol. 2025 Aug 7;16:1616113. doi: 10.3389/fimmu.2025.1616113. eCollection 2025.
5
Integrated system for screening tumor-specific TCRs, epitopes, and HLA subtypes using single-cell sequencing data.利用单细胞测序数据筛选肿瘤特异性TCR、表位和HLA亚型的集成系统。
J Immunother Cancer. 2025 Jul 31;13(7):e012029. doi: 10.1136/jitc-2025-012029.
6
High-throughput discovery of MHC class I- and II-restricted T cell epitopes using synthetic cellular circuits.利用合成细胞回路高通量发现MHC I类和II类限制性T细胞表位
Nat Biotechnol. 2025 Apr;43(4):623-634. doi: 10.1038/s41587-024-02248-6. Epub 2024 Jul 2.
7
Solution mapping of MHC-I:TCR interactions using a minimalistic protein system.使用简约蛋白质系统对MHC-I:TCR相互作用进行溶液图谱分析。
Proc Natl Acad Sci U S A. 2025 Jun 17;122(24):e2506016122. doi: 10.1073/pnas.2506016122. Epub 2025 Jun 9.
8
The role of Nef in the long-term persistence of the replication-competent HIV reservoir in South African women.Nef在南非女性体内具有复制能力的HIV病毒库长期存留中的作用。
J Virol. 2025 Jun 24:e0021725. doi: 10.1128/jvi.00217-25.
9
The ubiquitin-like modifier FAT10 is not essential for MHC-I antigen presentation.类泛素修饰因子FAT10对MHC-I抗原呈递并非必不可少。
Front Immunol. 2025 Aug 1;16:1636951. doi: 10.3389/fimmu.2025.1636951. eCollection 2025.
10
Alternate MHC I Antigen Presentation Pathways Allow CD8+ T-cell Recognition and Killing of Cancer Cells in the Absence of β2M or TAP.替代性MHC I类抗原呈递途径可使CD8+ T细胞在缺乏β2微球蛋白(β2M)或抗原加工相关转运体(TAP)的情况下识别并杀伤癌细胞。
Cancer Immunol Res. 2025 Jan 9;13(1):98-108. doi: 10.1158/2326-6066.CIR-24-0320.

本文引用的文献

1
TULIP: A transformer-based unsupervised language model for interacting peptides and T cell receptors that generalizes to unseen epitopes.TULIP:一种基于转换器的无监督语言模型,用于与肽和 T 细胞受体相互作用,可推广到未见的表位。
Proc Natl Acad Sci U S A. 2024 Jun 11;121(24):e2316401121. doi: 10.1073/pnas.2316401121. Epub 2024 Jun 5.
2
Adaptive immune receptor germline gene variation.适应性免疫受体种系基因变异。
Curr Opin Immunol. 2024 Apr;87:102429. doi: 10.1016/j.coi.2024.102429. Epub 2024 May 27.
3
Deep learning predictions of TCR-epitope interactions reveal epitope-specific chains in dual alpha T cells.
深度学习预测 TCR-表位相互作用揭示了双α T 细胞中表位特异性链。
Nat Commun. 2024 Apr 13;15(1):3211. doi: 10.1038/s41467-024-47461-8.
4
UCSF ChimeraX: Tools for structure building and analysis.UCSF ChimeraX:结构构建和分析工具。
Protein Sci. 2023 Nov;32(11):e4792. doi: 10.1002/pro.4792.
5
Measures of epitope binding degeneracy from T cell receptor repertoires.从 T 细胞受体库中测量表位结合简并性。
Proc Natl Acad Sci U S A. 2023 Jan 24;120(4):e2213264120. doi: 10.1073/pnas.2213264120. Epub 2023 Jan 17.
6
RCSB Protein Data Bank (RCSB.org): delivery of experimentally-determined PDB structures alongside one million computed structure models of proteins from artificial intelligence/machine learning.RCSB 蛋白质数据库(RCSB.org):提供实验测定的 PDB 结构以及来自人工智能/机器学习的 100 万个蛋白质计算结构模型。
Nucleic Acids Res. 2023 Jan 6;51(D1):D488-D508. doi: 10.1093/nar/gkac1077.
7
MHC Class I Immunopeptidome: Past, Present, and Future.MHC Ⅰ类免疫肽组学:过去、现在和未来。
Mol Cell Proteomics. 2022 Jul;21(7):100230. doi: 10.1016/j.mcpro.2022.100230. Epub 2022 Apr 5.
8
NetTCR-2.0 enables accurate prediction of TCR-peptide binding by using paired TCRα and β sequence data.NetTCR-2.0 通过使用配对的 TCRα 和β 序列数据实现了 TCR-肽结合的准确预测。
Commun Biol. 2021 Sep 10;4(1):1060. doi: 10.1038/s42003-021-02610-3.
9
SwarmTCR: a computational approach to predict the specificity of T cell receptors.SwarmTCR:一种预测 T 细胞受体特异性的计算方法。
BMC Bioinformatics. 2021 Sep 7;22(1):422. doi: 10.1186/s12859-021-04335-w.
10
Contribution of T Cell Receptor Alpha and Beta CDR3, MHC Typing, V and J Genes to Peptide Binding Prediction.T 细胞受体α和β CDR3、MHC 分型、V 和 J 基因对肽结合预测的贡献。
Front Immunol. 2021 Apr 26;12:664514. doi: 10.3389/fimmu.2021.664514. eCollection 2021.